On Monday, Wave Life Sciences Ltd (NASDAQ: WVE) was 5.82% up from the session before settling in for the closing price of $7.05. A 52-week range for WVE has been $5.28 – $16.38.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 34.27%. When this article was written, the company’s average yearly earnings per share was at -70.07%. With a float of $134.97 million, this company’s outstanding shares have now reached $160.29 million.
Wave Life Sciences Ltd (WVE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Wave Life Sciences Ltd stocks. The insider ownership of Wave Life Sciences Ltd is 19.27%, while institutional ownership is 82.42%. The most recent insider transaction that took place on Nov 13 ’25, was worth 109,421. In this transaction Director of this company sold 16,115 shares at a rate of $6.79, taking the stock ownership to the 12,700 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director bought 1,000 for $6.69, making the entire transaction worth $6,688. This insider now owns 18,203,009 shares in total.
Wave Life Sciences Ltd (WVE) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.27 earnings per share (EPS) during the time that was better than consensus figure (set at -0.22) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -70.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.49% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
You can see what Wave Life Sciences Ltd (WVE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.18 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Compared to the last year’s volume of 1.73 million, its volume of 2.43 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 55.36%.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 23.37%, which indicates a significant decrease from 58.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.55 in the past 14 days, which was higher than the 0.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.39, while its 200-day Moving Average is $7.89. Nevertheless, the first resistance level for the watch stands at $7.65 in the near term. At $7.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.12. If the price goes on to break the first support level at $7.18, it is likely to go to the next support level at $6.90. Now, if the price goes above the second support level, the third support stands at $6.71.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are 167,182K outstanding shares of the company, which has a market capitalization of 1.25 billion. As of now, sales total 108,300 K while income totals -97,010 K. Its latest quarter income was 7,610 K while its last quarter net income were -53,850 K.
